BioGaia AB (LTS:0GTN) Pre-Tax Income : kr469 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. BioGaia AB's pretax income for the three months ended in Dec. 2023 was kr88 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was kr469 Mil. BioGaia AB's pretax margin was 29.62%.

During the past 13 years, BioGaia AB's highest Pretax Margin was 40.55%. The lowest was 30.46%. And the median was 36.75%.

BioGaia AB Pre-Tax Income Historical Data

The historical data trend for BioGaia AB's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Pre-Tax Income Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

242.26

227.58

252.71

447.61

468.83

BioGaia AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															152.45	150.56	102.06	128.02	88.19

Competitive Comparison of BioGaia AB's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Pre-Tax Income falls into.

BioGaia AB Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

BioGaia AB's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	441.257	+	0	+	-0.809	+	41.532	+	-13.146
	=	469

BioGaia AB's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	78.684	+	0	+	1.785	+	20.868	+	-13.146
	=	88

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr469 Mil.

BioGaia AB (LTS:0GTN) Pre-Tax Income Explanation

BioGaia AB's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	88.191	/	297.773
	=	29.62%

During the past 13 years, BioGaia AB's highest Pretax Margin was 40.55%. The lowest was 30.46%. And the median was 36.75%.

BioGaia AB Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB (LTS:0GTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

BIOGY:USA BGLAF:USA BIOG B:Sweden BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines